Abiopharma

XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference

BridgeBio to Host Autosomal Dominant Hypocalcemia Type 1 (ADH1) Investor Webinar on Wednesday, September 10th at 8:00 am ET

Cybin to Participate in the Cantor Global Healthcare Conference 2025

Cognition Therapeutics Study of Zervimesine (CT1812) in Early Alzheimer’s Disease Reaches 75% Enrollment Target

New Form 8-K - Kymera Therapeutics, Inc. Filed: 2025-09-03 AccNo: 0001193125-25-194481 Size: 155 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - SONO TEK CORP Filed: 2025-09-03 AccNo: 0001171520-25-000283 Size: 371 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 6-K - PURPLE BIOTECH LTD. Filed: 2025-09-03 AccNo: 0001213900-25-083700 Size: 25 KB

New Form 8-K - PRECIGEN, INC. Filed: 2025-09-03 AccNo: 0001104659-25-086669 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and …

New Form 8-K - FRACTYL HEALTH, INC. Filed: 2025-09-03 AccNo: 0000950170-25-112671 Size: 156 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form 8-K - ProMIS Neurosciences Inc. Filed: 2025-09-03 AccNo: 0001558370-25-011845 Size: 206 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Perspective Therapeutics, Inc. Filed: 2025-09-03 AccNo: 0000728387-25-000010 Size: 267 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Aldeyra Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Centessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Travere Therapeutics Presents Abstracts at the 15th International Congress of Inborn Errors of Metabolism

XORTX Initiates IND Preparation for XORLO™ in Gout Program